Applied genetic technologies corporation
Investors. AGTC is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system …Company Profile. Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company uses gene therapy platform to develop genetic …
Did you know?
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops gene therapy products for inherited orphan ophthalmology diseases in the United States. The company’s lead product candidates in the preclinical stage comprise treatments for X-linked retinoschisis, Congenital Achromatopsia, and X-linked retinitis pigmentosa, …Applied Genetic Technologies Corporation T: (617) 843-5728 [email protected]. Stephen Potter Chief Business Officer Applied Genetic Technologies Corporation T: (617) 413-2754Visionary science for life-changing cures. | AGTC is a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop products designed to transform …GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno ...Apr 13, 2021 · Applied Genetic Technologies Corporation T: (617) 413-2754 [email protected] ... Applied Genetic Technologies Corporation had $90.5 million as of September 30, 2021; enough cash to fund its operations into 2023. Read more on AGTC stock here.On August 23, 2022, the Board of Directors of Applied Genetic Technologies Corporation (the “Company”) approved the bonus payment for the fiscal year ended June 30, 2022 and salary change for the fiscal year ending June 30, 2023 for the Company’s Chief Executive Officer, which are set forth in the following table.GAINESVILLE, Fla., and CAMBRIDGE, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), a clinical-stage biotechnology ...Dec 1, 2022 · Applied Genetic Technologies Corporation (AGTC) · Syncona to invest $23.3 million upfront to acquire AGTC. · AGTC to become Syncona's third retinal gene therapy company, focused on driving AGTC-501, for X-linked retinitis pigmentosa, through late-stage clinical development. Jul 13, 2022 · GAINESVILLE, Fla., and CAMBRIDGE, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), a clinical-stage biotechnology ... Conference Call and Webcast. Syncona and AGTC will host a conference call and webcast to review the details of the transaction on October 24, 2022 at 7:30 a.m. ET. To access the call, dial 877-407-6184 (U.S. participants) or 201-389-0877 (non-U.S. participants). A live webcast will be available in the Events and Presentations section of AGTC ...22 oct. 2019 ... Applied Genetic Technologies Corporation (AGTC), a clinical-stage biotechnology company, developing transformational genetic therapies for ...In today’s digital age, businesses of all sizes are increasingly relying on technology to conduct their operations. With the rise of remote work and the growing number of devices connected to corporate networks, ensuring the security of end...Applied Genetic Technologies Corporation T: (617) 843-5728 [email protected]. Stephen Potter Chief Business Officer Applied Genetic Technologies Corporation T: (617) 413-2754In today’s technology-driven world, computer IT services play a vital role in the success of modern businesses. From small startups to large corporations, businesses rely heavily on computers and technology to streamline operations and driv...Applied Genetic Technologies Corporation . 14193 NW 119 th Terrace, Suite 10 . Alachua, Florida 32615 (386) 462-2204 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications . on Behalf of the Person(s) Filing Statement) With copies to:Search 1 job openings at Applied Genetics Technologies Corporation. Find the the right Applied Genetics Technologies Corporation job for you in Cambridge, ...Jun 12, 2023 · gchutka via Getty Images. Backed by millions of dollars of funding and a team of drug industry veterans, a new biotechnology company aims to create genetic medicines for eye diseases that lead to blindness. Beacon Therapeutics was founded earlier this year and has raised 96 million British pounds, or roughly $120 million, to support its mission.
Aug 19, 2021 · Applied Genetic Technologies Corporation T: (617) 413-2754 [email protected] ... Applied Genetic Technologies Corporation (AGTC) is developing a recombinant adeno-associated virus (rAAV) vector AGTC-501, also designated rAAV2tYF-GRK1-hRPGRco, to treat X-linked retinitis pigmentosa (XLRP) in patients with mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene.October 24, 2022. Venture firm Syncona is acquiring Applied Genetic Technologies Corporation, a company focused on the development and commercialization of adeno-associated virus-based gene therapies for the treatment of rare and debilitating diseases with an initial focus on inherited retinal diseases, for approximately $23.5 million plus ...Applied Genetic Technologies Corporation Reminds Shareholders to Tender Their Shares by November 28, 2022. GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Applied Genetic ...In today’s digital age, technology has made it easier than ever to access information and services online. This includes applying for government schemes like Ayushman Bharat, which aims to provide health insurance coverage to millions of In...
However, a novel new gene therapy is being developed by AGTC-501 (Applied Genetic Technologies Corporation), and recently passed the safety tests of ...GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno ...…
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. GAINESVILLE, Fla., and CAMBRIDGE, Mass., July 12, 2022 (GLOBE NEWSW. Possible cause: Introductory Note As previously disclosed on a Form 8-K filed with the Securities.
APPLIED GENETIC TECHNOLOGIES CORPORATION CONDENSED BALANCE SHEETS (Unaudited) In thousands. September 30, 2021. June 30, 2021. ASSETS. Current assets: Cash and cash equivalents $ 90,515 $ 105,052.On January 11, 2022, Applied Genetic Technologies Corporation issued a press release announcing updated information regarding its ongoing X-linked retinitis pigmentosa (XLRP) clinical trials. A copy of this press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.The Applied Genetic Technologies Corporation is a publicly traded (Nasdaq: AGTC) biotechnology company that is part of the NASDAQ Biotechnology Index. It was founded in 1999 and has its headquarters in Alachua, Florida. In late June 2019, the company announced the appointment of Global Clinical and Medical Affairs Veteran, Theresa G.H. Heah, M.D., M.B.A., to Join as Chief Medical Of…
Applied Genetic Technologies Corporation, a Cambridge- and Florida-based gene therapy firm better known as AGTC could go private through an acquisition by a Floridian investment firm.On June 7, 2022, Applied Genetic Technologies Corporation (the "Company") received written notice from The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company is not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Global Market, as set forth in Listing …
Applied Genetic Technologies Corporation Con The Company’s filings with the SEC are available to the public from the website maintained by the SEC at www.sec.gov. Additional copies of the tender offer materials may be obtained for free by contacting Applied Genetic Technologies Corporation at 14196 NW 119 th Terrace, Suite 10, Alachua, Florida, 32165, Attention: Chief Financial Officer. Applied Genetic Technologies Corporation T: (617) October 24, 2022. Venture firm Syncona is acquiring GAINESVILLE, Fla., and CAMBRIDGE, Mass., July 07, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical-stage biotechnology company focused on the ... Applied Genetic Technologies Corporation . 14193 NW 119 th Terrace, Nov 9, 2021 · Applied Genetic Technologies Corporation T: (617) 843-5778 [email protected] ... October 24, 2022. Venture firm Syncona is acquirinGAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 202Applied Genetic Technologies Company Info. Applied Genetic Applied Genetic Technologies Corporation T: (617) 843-5778 [email protected] ...GAINESVILLE, Fla. and CAMBRIDGE, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), a clinical-stage biotechnology ... To wit, the Applied Genetic Technologies Corporation (NA On August 23, 2022, the Board of Directors of Applied Genetic Technologies Corporation (the “Company”) approved the bonus payment for the fiscal year ended June 30, 2022 and salary change for the fiscal year ending June 30, 2023 for the Company’s Chief Executive Officer, which are set forth in the following table. Dec 1, 2022 · GAINESVILLE, Fla. and CAMB[APPLIED GENETIC TECHNOLOGIES CORPORATION: BALANCE SHEEApplied Genetic Technologies Corporation T: (617) 843-5728 Whether you want to file a complaint, ask a question or apply for a job, there are many reasons why you may need to reach a company’s corporate office. While the details for every company are somewhat different, you can try these steps to f...